Pharmacological Activities and Molecular Mechanisms of Sinapic Acid in Neurological Disorders Publisher Pubmed



Farzan M^{1, 2} ; Abedi B³ ; Bhia I⁴ ; Madanipour A⁵ ; Farzan M^{1, 2} ; Bhia M⁶ ; Aghaei A¹ ; Kheirollahi I⁷ ; Motallebi M⁸ ; Aminikhoei H² ; Ertas YN^{9, 10}
Source: ACS Chemical Neuroscience Published:2024

Abstract

Sinapic acid (SA) is a phenylpropanoid derivative found in various natural sources that exhibits remarkable versatile properties, including antioxidant, anti-inflammatory, and metal-chelating capabilities, establishing itself as a promising candidate for the prevention and treatment of conditions affecting the central nervous system, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), ischemic stroke, and other neurological disorders. These effects also include neuroprotection in epilepsy models, as evidenced by a reduction in seizure-like behavior, cell death in specific hippocampal regions, and lowered neuroinflammatory markers. In AD, SA treatment enhances memory, reverses cognitive deficits, and attenuates astrocyte activation. SA also has positive effects on cognition by improving memory and lowering oxidative stress. This is shown by lower levels of oxidative stress markers, higher levels of antioxidant enzyme activity, and better memory retention. Additionally, in ischemic stroke and PD models, SA provides microglial protection and exerts anti-inflammatory effects. This review emphasizes SA’s multifaceted neuroprotective properties and its potential role in the prevention and treatment of various brain disorders. Despite the need for further research to fully understand its mechanisms of action and clinical applicability, SA stands out as a valuable bioactive compound in the ongoing quest to combat neurodegenerative diseases and enhance the quality of life for affected individuals. © 2024 American Chemical Society